Applicant, as named in the Orange Book

Napo Pharms Inc

Next listed expiry: Mytesi on 31 Oct 2031. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Mytesi crofelemer	crofelemer	202292	31 Oct 2031	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.